- Buyer
- Instytut "Pomnik-Centrum Zdrowia Dziecka"
- Supplier named in sources
- Ryvu Therapeutics S.A.
- CPV categories
- 33600000
Awarded contract
ZP/CZD/062/26 Dostawa badanego produktu leczniczego ROMACICLIB (RVU 120) do zastosowania w ramach niekomercyjnego badania klinicznego MEDWAY „Badanie fazy I dotyczące stosowania inhibitora CDK8 RVU120 w połączeniu z ewerolimusem u dzieci z nawracającym lub postępującym medulloblastoma grupy 3 lub 4"
Show full titleHide full title
The record names Instytut "Pomnik-Centrum Zdrowia Dziecka" as the buyer and Ryvu Therapeutics S.A. as the source-named supplier. The disclosed monetary value is PLN 1,732,782.91 (final award value). DemandTrace associates this award with the listed issuer group Ryvu Therapeutics S.A. (Medium confidence); the association follows the source-identified supplier and does not by itself assert that the listed company was the contracting party. The information became publicly knowable on 25 Aug 2026; the source record was published on 25 Aug 2026. Official source: Public procurement record.
Descriptive public record of one awarded procurement event. Amounts, when shown, are the disclosed headline value of this individual contract, not totals.